James E Flynn Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James E Flynn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James E Flynn. James E Flynn is a 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and a 10% Owner in AxoGen, Inc. ($LECT) and a 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and a 10% Owner in Fibrocell Science, Inc. ($FCSC) and a 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and a 10% Owner in ANTARES PHARMA, INC. ($ATRS) and a 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and a 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and a 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and a 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and a 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and a 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and a 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and a 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and a 10% Owner in MEDICINES CO /DE ($MDCO) and a 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and a 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and a 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and a Director in Talon Therapeutics, Inc. ($EMLR) and a 10% Owner in LUMOS PHARMA, INC. ($NLNK) and a 10% Owner in NITROMED INC ($NTMD) and a 10% Owner in XENOPORT INC ($XNPT) and a 10% Owner in EMAGEON INC ($EMAG) and a 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and a 10% Owner in ALIMERA SCIENCES INC ($ALIM) and a 10% Owner in NeuroMetrix, Inc. ($NURO) and a 10% Owner in NxStage Medical, Inc. ($NXTM) and a 10% Owner in aTYR PHARMA INC ($LIFE) and a 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and a 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and a Director in PROTEON THERAPEUTICS INC ($PRTO) and a 10% Owner in eHealth, Inc. ($EHTH) and a 10% Owner in ZAFGEN, INC. ($ZFGN) and a 10% Owner in NeurogesX Inc ($NGSX) and a 10% Owner in Invuity, Inc. ($IVTY) and a 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and a 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and a 10% Owner in TriVascular Technologies, Inc. ($TRIV) and a 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and a 10% Owner in Neos Therapeutics, Inc. ($NEOS) and a 10% Owner in Schrodinger, Inc. ($SDGR) and a 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and a Director in Acutus Medical, Inc. ($AFIB) and a 10% Owner in Annexon, Inc. ($ANNX) and a 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and a 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and a 10% Owner in Mallinckrodt plc ($MNK) and a 10% Owner in Loxo Oncology, Inc. ($LOXO) and a 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and a 10% Owner in REGENXBIO Inc. ($RGNX) and a 10% Owner in Recro Pharma, Inc. ($REPH) and a 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and a Director in Nivalis Therapeutics, Inc. ($NVLS) and a 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and a 10% Owner in SteadyMed Ltd. ($STDY) and a 10% Owner in ShockWave Medical, Inc. ($SWAV) and a 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a 10% Owner in Editas Medicine, Inc. ($EDIT) and a Director in AveXis, Inc. ($AVXS) and a 10% Owner in ARVINAS INC. ($ARVN) and a 10% Owner in Homology Medicines, Inc. ($FIXX) and a Director in Homology Medicines, Inc. ($FIXX) and a Director in Oncorus, Inc. ($ONCR) and a 10% Owner in Revolution Medicines, Inc. ($RVMD) and a 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and a 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and a Director in DFB Healthcare Acquisitions Corp. ($DFBH) and a 10% Owner in Generation Bio Co. ($GBIO) and a 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and a 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and a 10% Owner in Cabaletta Bio, Inc. ($CABA) and a 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and a 10% Owner in Nkarta, Inc. ($NKTX) and a 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and a Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and a Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and a 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).

Over the past year James E Flynn has been an insider in 10 companies. The total value of shares held by James E Flynn in these companies amounts to $12,414,862.

James E Flynn 10% Owner
Aclaris Therapeutics, Inc.
Director
Acutus Medical, Inc.
Director
AdaptHealth Corp.
10% Owner
Adverum Biotechnologies, Inc.
10% Owner
ALIMERA SCIENCES INC
Director, 10% Owner
ALPINE IMMUNE SCIENCES, INC.
10% Owner
Annexon, Inc.
10% Owner
ANTARES PHARMA, INC.
10% Owner
ARENA PHARMACEUTICALS INC
10% Owner
ARVINAS, INC.
10% Owner
aTYR PHARMA INC
10% Owner
Audentes Therapeutics, Inc.
10% Owner
Auspex Pharmaceuticals, Inc.
10% Owner
AVADEL PHARMACEUTICALS PLC
Director
AveXis, Inc.
10% Owner
Axogen, Inc.
10% Owner
Black Diamond Therapeutics, Inc.
10% Owner
Cabaletta Bio, Inc.
10% Owner
CAS MEDICAL SYSTEMS INC
10% Owner
CATALYST BIOSCIENCES, INC.
10% Owner
CONSTELLATION PHARMACEUTICALS INC
10% Owner
Cyclacel Pharmaceuticals, Inc.
10% Owner
CytomX Therapeutics, Inc.
Director
Deerfield Healthcare Technology Acquisitions Corp.
Director
DFP HEALTHCARE ACQUISITIONS CORP.
10% Owner
Dicerna Pharmaceuticals Inc
10% Owner
DUSA PHARMACEUTICALS INC
10% Owner
DYNAVAX TECHNOLOGIES CORP
10% Owner
Edgewise Therapeutics, Inc.
10% Owner
Editas Medicine, Inc.
10% Owner
eHealth, Inc.
10% Owner
EMAGEON INC
10% Owner
Fibrocell Science, Inc.
10% Owner
Frequency Therapeutics, Inc.
10% Owner
Generation Bio Co.
10% Owner
HI TECH PHARMACAL CO INC
10% Owner, Director
Homology Medicines, Inc.
10% Owner
INSPIRE PHARMACEUTICALS INC
10% Owner
Invuity, Inc.
10% Owner
ISTA PHARMACEUTICALS INC
10% Owner
Kiniksa Pharmaceuticals, Ltd.
10% Owner
Larimar Therapeutics, Inc.
10% Owner
Loxo Oncology, Inc.
10% Owner
LUMOS PHARMA, INC.
10% Owner
Mallinckrodt plc
10% Owner
MEDICINES CO /DE
10% Owner
Mirum Pharmaceuticals, Inc.
10% Owner
Neos Therapeutics, Inc.
10% Owner
NeurogesX Inc
10% Owner
NeuroMetrix, Inc.
10% Owner
NITROMED INC
10% Owner
Nkarta, Inc.
10% Owner
NxStage Medical, Inc.
Director
Oncorus, Inc.
10% Owner
PAR PHARMACEUTICAL COMPANIES, INC.
Director
Protara Therapeutics, Inc.
10% Owner
Recro Pharma, Inc.
10% Owner
REGENXBIO Inc.
10% Owner
Revolution Medicines, Inc.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
10% Owner
RIGEL PHARMACEUTICALS INC
10% Owner
Schrodinger, Inc.
10% Owner
Shockwave Medical, Inc.
10% Owner
SteadyMed Ltd.
10% Owner
STREAMLINE HEALTH SOLUTIONS INC.
10% Owner
Syros Pharmaceuticals, Inc.
Director
Talon Therapeutics, Inc.
10% Owner
Terns Pharmaceuticals, Inc.
10% Owner
THIRD WAVE TECHNOLOGIES INC /WI
10% Owner
TriVascular Technologies, Inc.
10% Owner
Vanda Pharmaceuticals Inc.
10% Owner
VIA Pharmaceuticals, Inc.
10% Owner
Werewolf Therapeutics, Inc.
10% Owner
XENOPORT INC
10% Owner
XERIS PHARMACEUTICALS INC
$ 12414862 The total value of shares held by James E Flynn
Insider Rank

James E Flynn ranks 2,270 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: 780 THIRD AVENUE 37TH FLOOR NEW YORK 10017 NY

Companies in which James E Flynn is an Insider

Aclaris Therapeutics, Inc.

Trading Symbol: ACRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 964,101 shares
Current Value: $24,343,550
Latest Transaction: Jul 01 2019
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 14x
Shares Bought: 0
Shares Sold: 1,770,150
Share Difference: -1,770,150
Value Difference: +$7,740,508

Acutus Medical, Inc.

Trading Symbol: AFIB
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: Director
Holdings: 2,222 shares
Latest Transaction: Aug 12 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 0x
Shares Bought: 4,344,024
Shares Sold: 0
Share Difference: +4,344,024
Value Difference: -$27,000,000

AdaptHealth Corp.

Trading Symbol: DFBH
Industry: SERVICES-HOME HEALTH CARE SERVICES [8082]
Position of James E Flynn: Director
Holdings: 14,900,000 shares
Latest Transaction: Nov 13 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 10x
Shares Bought: 52,100,000
Shares Sold: 3,559,121
Share Difference: +48,540,879
Value Difference: -$496,000,000

Adverum Biotechnologies, Inc.

Trading Symbol: ADVM
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 627,267 shares
Latest Transaction: Aug 05 2014

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ALIMERA SCIENCES INC

Trading Symbol: ALIM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 728,718 shares
Current Value: $845,313
Latest Transaction: Dec 08 2015
$ALIM Market Capitalization: $75.24M
$ALIM Previous Close: $1.16

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ALPINE IMMUNE SCIENCES, INC.

Trading Symbol: ALPN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: Director, 10% Owner
Holdings: 832,216 shares
Current Value: $1,947,385
Latest Transaction: Sep 14 2016
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Annexon, Inc.

Trading Symbol: ANNX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 458,914 shares
Latest Transaction: Jul 28 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 1,617,828
Shares Sold: 0
Share Difference: +1,617,828
Value Difference: -$11,900,000

ANTARES PHARMA, INC.

Trading Symbol: ATRS
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 5,348,776 shares
Current Value: $11,767,307
Latest Transaction: Sep 30 2015
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ARENA PHARMACEUTICALS INC

Trading Symbol: ARNA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 3,238,908 shares
Current Value: $4,825,973
Latest Transaction: Oct 23 2007
$ARNA Market Capitalization: $357.67M
$ARNA Previous Close: $1.49

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ARVINAS, INC.

Trading Symbol: ARVN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 307,078 shares
Latest Transaction: Oct 01 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 1,233,734
Shares Sold: 0
Share Difference: +1,233,734
Value Difference: -$5,000,000

aTYR PHARMA INC

Trading Symbol: LIFE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 255,764 shares
Current Value: $869,598
Latest Transaction: May 13 2015
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Audentes Therapeutics, Inc.

Trading Symbol: BOLD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 535,996 shares
Current Value: $8,484,817
Latest Transaction: Jul 25 2016
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 1,403,654
Shares Sold: 0
Share Difference: +1,403,654
Value Difference: -$6,000,000

Auspex Pharmaceuticals, Inc.

Trading Symbol: ASPX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 0 shares
Latest Transaction: May 07 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

AVADEL PHARMACEUTICALS PLC

Trading Symbol: AVDL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 952,265 shares
Latest Transaction: Jun 25 2018

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 1x
Shares Bought: 0
Shares Sold: 114,034
Share Difference: -114,034
Value Difference: +$683,315

AveXis, Inc.

Trading Symbol: AVXS
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: Director
Holdings: 112,000 shares
Current Value: $6,602,400
Latest Transaction: Feb 19 2016
$AVXS Market Capitalization: $1.59B
$AVXS Previous Close: $58.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Axogen, Inc.

Trading Symbol: LECT
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of James E Flynn: 10% Owner
Holdings: 3,000,000 shares
Latest Transaction: Jul 21 2016

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 4x
Shares Bought: 0
Shares Sold: 381,439
Share Difference: -381,439
Value Difference: +$2,788,482

Black Diamond Therapeutics, Inc.

Trading Symbol: BDTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 378,790 shares
Latest Transaction: Feb 03 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 778,790
Shares Sold: 0
Share Difference: +778,790
Value Difference: -$7,600,000

Cabaletta Bio, Inc.

Trading Symbol: CABA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 464,253 shares
Latest Transaction: Oct 30 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 1,628,506
Shares Sold: 0
Share Difference: +1,628,506
Value Difference: -$7,700,000

CAS MEDICAL SYSTEMS INC

Trading Symbol: CAMY.OB
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 2,947,554 shares
Latest Transaction: Jan 26 2017

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 6x
Shares Bought: 0
Shares Sold: 841,364
Share Difference: -841,364
Value Difference: +$1,244,582

CATALYST BIOSCIENCES, INC.

Trading Symbol: CBIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,171,839 shares
Current Value: $691,385
Latest Transaction: Mar 08 2018
$CBIO Market Capitalization: $6.51M
$CBIO Previous Close: $0.59

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 5x
Shares Bought: 0
Shares Sold: 71,778
Share Difference: -71,778
Value Difference: +$2,191,045

CONSTELLATION PHARMACEUTICALS INC

Trading Symbol: CNST
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 635,843 shares
Latest Transaction: Jul 23 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 835,843
Shares Sold: 0
Share Difference: +835,843
Value Difference: -$3,000,000

Cyclacel Pharmaceuticals, Inc.

Trading Symbol: CYCC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 881,743 shares
Latest Transaction: Nov 20 2008

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CytomX Therapeutics, Inc.

Trading Symbol: CTMX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 275,000 shares
Current Value: $3,162,500
Latest Transaction: Oct 14 2015
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Deerfield Healthcare Technology Acquisitions Corp.

Trading Symbol: DFHTW
Industry: SERVICES-NURSING & PERSONAL CARE FACILITIES [8050]
Position of James E Flynn: Director
Holdings: 3,360,000 shares
Latest Transaction: Jul 22 2020

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 3,360,000
Shares Sold: 0
Share Difference: +3,360,000
Value Difference: -$33,600,000

DFP HEALTHCARE ACQUISITIONS CORP.

Trading Symbol: DFPHU
Industry: BLANK CHECKS [6770]
Position of James E Flynn: Director
Holdings: 2,500,000 shares
Latest Transaction: Mar 17 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 5,000,000
Shares Sold: 0
Share Difference: +5,000,000
Value Difference: -$50,000,000

Dicerna Pharmaceuticals Inc

Trading Symbol: DRNA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 972,642 shares
Current Value: $2,509,416
Latest Transaction: Feb 04 2014
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

DUSA PHARMACEUTICALS INC

Trading Symbol: DUSA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,952,648 shares
Latest Transaction: Jun 26 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

DYNAVAX TECHNOLOGIES CORP

Trading Symbol: DVAX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 24 2008
$DVAX Market Capitalization: $154.11M
$DVAX Previous Close: $3.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Edgewise Therapeutics, Inc.

Trading Symbol: EWTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,572,960 shares
Latest Transaction: Mar 30 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 3,933,137
Shares Sold: 0
Share Difference: +3,933,137
Value Difference: -$10,000,000

Editas Medicine, Inc.

Trading Symbol: EDIT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 954,700 shares
Current Value: $17,719,232
Latest Transaction: Feb 08 2016
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

eHealth, Inc.

Trading Symbol: EHTH
Industry: INSURANCE AGENTS BROKERS & SERVICES [6411]
Position of James E Flynn: 10% Owner
Holdings: 428,367 shares
Current Value: $4,917,653
Latest Transaction: Apr 27 2017
$EHTH Market Capitalization: $204.50M
$EHTH Previous Close: $11.48

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 30x
Shares Bought: 0
Shares Sold: 1,433,034
Share Difference: -1,433,034
Value Difference: +$18,050,428

EMAGEON INC

Trading Symbol: EMAG
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of James E Flynn: 10% Owner
Holdings: 1,173,658 shares
Latest Transaction: Mar 02 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Fibrocell Science, Inc.

Trading Symbol: FCSC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,162,800 shares
Current Value: $813,960
Latest Transaction: Aug 18 2010
$FCSC Market Capitalization: $30.78M
$FCSC Previous Close: $0.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Frequency Therapeutics, Inc.

Trading Symbol: FREQ
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 472,860 shares
Latest Transaction: Oct 07 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 1,231,434
Shares Sold: 0
Share Difference: +1,231,434
Value Difference: -$3,999,996

Generation Bio Co.

Trading Symbol: GBIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 703,332 shares
Latest Transaction: Jun 16 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 1,186,215
Shares Sold: 0
Share Difference: +1,186,215
Value Difference: -$4,275,000

HI TECH PHARMACAL CO INC

Trading Symbol: HITK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 346,016 shares
Latest Transaction: Dec 13 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Homology Medicines, Inc.

Trading Symbol: FIXX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner, Director
Holdings: 509,970 shares
Latest Transaction: Jan 31 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 19x
Shares Bought: 5,760,368
Shares Sold: 1,837,793
Share Difference: +3,922,575
Value Difference: +$909,043

INSPIRE PHARMACEUTICALS INC

Trading Symbol: ISPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 2,307,449 shares
Latest Transaction: May 02 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Invuity, Inc.

Trading Symbol: IVTY
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 1,807,239 shares
Current Value: $12,650,673
Latest Transaction: Dec 14 2016
$IVTY Market Capitalization: $117.66M
$IVTY Previous Close: $7.00

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 3x
Shares Bought: 0
Shares Sold: 184,796
Share Difference: -184,796
Value Difference: +$1,148,909

ISTA PHARMACEUTICALS INC

Trading Symbol: ISTA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 551,099 shares
Latest Transaction: May 06 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Kiniksa Pharmaceuticals, Ltd.

Trading Symbol: KNSA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 383,538 shares
Latest Transaction: May 31 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 1,226,890
Shares Sold: 0
Share Difference: +1,226,890
Value Difference: -$15,996,834

Larimar Therapeutics, Inc.

Trading Symbol: LRMR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 247,413 shares
Current Value: $1,014,393
Latest Transaction: Aug 01 2016
$LRMR Market Capitalization: $109.05M
$LRMR Previous Close: $4.10

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 3x
Shares Bought: 0
Shares Sold: 1,341,499
Share Difference: -1,341,499
Value Difference: +$4,442,777

Loxo Oncology, Inc.

Trading Symbol: LOXO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 296,125 shares
Current Value: $11,756,163
Latest Transaction: Aug 06 2014
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

LUMOS PHARMA, INC.

Trading Symbol: NLNK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 908,183 shares
Current Value: $12,414,862
Latest Transaction: Jan 08 2021
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 7x
Shares Bought: 0
Shares Sold: 151,723
Share Difference: -151,723
Value Difference: +$3,425,623

Mallinckrodt plc

Trading Symbol: MNK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 8,510,461 shares
Current Value: $431,310,163
Latest Transaction: May 10 2018
$MNK Market Capitalization: $5.32B
$MNK Previous Close: $50.68

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 2x
Shares Bought: 0
Shares Sold: 312,928
Share Difference: -312,928
Value Difference: +$4,189,818

MEDICINES CO /DE

Trading Symbol: MDCO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 3,035,472 shares
Current Value: $140,542,354
Latest Transaction: Apr 06 2011
$MDCO Market Capitalization: $3.32B
$MDCO Previous Close: $46.30

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Mirum Pharmaceuticals, Inc.

Trading Symbol: MIRM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,558,456 shares
Latest Transaction: Jul 24 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 3,448,912
Shares Sold: 0
Share Difference: +3,448,912
Value Difference: -$4,980,000

Neos Therapeutics, Inc.

Trading Symbol: NEOS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 429,166 shares
Current Value: $2,145,830
Latest Transaction: Jul 28 2015
$NEOS Market Capitalization: $81.10M
$NEOS Previous Close: $5.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NeurogesX Inc

Trading Symbol: NGSX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 987,880 shares
Latest Transaction: Jul 15 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NeuroMetrix, Inc.

Trading Symbol: NURO
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 781,833 shares
Current Value: $539,465
Latest Transaction: Dec 14 2010
$NURO Market Capitalization: $3.81M
$NURO Previous Close: $0.69

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NITROMED INC

Trading Symbol: NTMD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 46,085,133 shares
Latest Transaction: Apr 27 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Nkarta, Inc.

Trading Symbol: NKTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 709,936 shares
Latest Transaction: Jul 14 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 2,419,872
Shares Sold: 0
Share Difference: +2,419,872
Value Difference: -$18,000,000

NxStage Medical, Inc.

Trading Symbol: NXTM
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of James E Flynn: 10% Owner
Holdings: 1,292,874 shares
Current Value: $35,916,040
Latest Transaction: Dec 15 2009
$NXTM Market Capitalization: $1.80B
$NXTM Previous Close: $27.78

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Oncorus, Inc.

Trading Symbol: ONCR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: Director
Holdings: 620,480 shares
Latest Transaction: Oct 08 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 2,848,970
Shares Sold: 0
Share Difference: +2,848,970
Value Difference: -$15,000,000

PAR PHARMACEUTICAL COMPANIES, INC.

Trading Symbol: PRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 2,173,177 shares
Latest Transaction: Feb 01 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Protara Therapeutics, Inc.

Trading Symbol: TARA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: Director
Holdings: 197,424 shares
Current Value: $384,977
Latest Transaction: Jun 12 2018
$TARA Market Capitalization: $31.94M
$TARA Previous Close: $1.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 1x
Shares Bought: 110,557
Shares Sold: 110,557
Share Difference: 0
Value Difference: $0

Recro Pharma, Inc.

Trading Symbol: REPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,277,132 shares
Current Value: $10,280,913
Latest Transaction: Jun 14 2017
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 5x
Shares Bought: 0
Shares Sold: 173,315
Share Difference: -173,315
Value Difference: +$1,150,235

REGENXBIO Inc.

Trading Symbol: RGNX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 49,000 shares
Current Value: $840,350
Latest Transaction: Sep 22 2015
$RGNX Market Capitalization: $465.96M
$RGNX Previous Close: $17.15

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Revolution Medicines, Inc.

Trading Symbol: RVMD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 997,589 shares
Latest Transaction: Feb 18 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 2,096,384
Shares Sold: 0
Share Difference: +2,096,384
Value Difference: -$10,200,000

RHYTHM PHARMACEUTICALS, INC.

Trading Symbol: RYTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 291,005 shares
Latest Transaction: Oct 10 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 937,010
Shares Sold: 0
Share Difference: +937,010
Value Difference: -$6,035,000

RIGEL PHARMACEUTICALS INC

Trading Symbol: RIGL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 3,204,167 shares
Current Value: $7,850,209
Latest Transaction: Jun 07 2011
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Schrodinger, Inc.

Trading Symbol: SDGR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,346,167 shares
Latest Transaction: Feb 10 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 1,596,167
Shares Sold: 0
Share Difference: +1,596,167
Value Difference: -$4,250,000

Shockwave Medical, Inc.

Trading Symbol: SWAV
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 132,740 shares
Latest Transaction: Mar 11 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 0x
Shares Bought: 342,146
Shares Sold: 0
Share Difference: +342,146
Value Difference: -$510,000

SteadyMed Ltd.

Trading Symbol: STDY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 823,529 shares
Current Value: $2,552,940
Latest Transaction: Mar 25 2015
$STDY Market Capitalization: $68.47M
$STDY Previous Close: $3.10

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

STREAMLINE HEALTH SOLUTIONS INC.

Trading Symbol: LANV
Industry: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
Position of James E Flynn: 10% Owner
Holdings: 1,875,500 shares
Latest Transaction: Dec 17 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Syros Pharmaceuticals, Inc.

Trading Symbol: SYRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,186,654 shares
Current Value: $12,958,262
Latest Transaction: Jul 06 2016
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 16x
Sell: 0x
Shares Bought: 8,380,880
Shares Sold: 0
Share Difference: +8,380,880
Value Difference: -$20,000,000

Talon Therapeutics, Inc.

Trading Symbol: EMLR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: Director
Holdings: 0 shares
Latest Transaction: Jul 18 2013

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Terns Pharmaceuticals, Inc.

Trading Symbol: TERN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,717,033 shares
Latest Transaction: Feb 09 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 2,382,033
Shares Sold: 0
Share Difference: +2,382,033
Value Difference: -$11,305,000

THIRD WAVE TECHNOLOGIES INC /WI

Trading Symbol: TWTI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 734,795 shares
Latest Transaction: May 22 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

TriVascular Technologies, Inc.

Trading Symbol: TRIV
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 261,143 shares
Latest Transaction: Apr 22 2014

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Vanda Pharmaceuticals Inc.

Trading Symbol: VNDA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,873,108 shares
Current Value: $25,567,924
Latest Transaction: Sep 26 2016
$VNDA Market Capitalization: $628.43M
$VNDA Previous Close: $13.65

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 15x
Shares Bought: 0
Shares Sold: 1,668,347
Share Difference: -1,668,347
Value Difference: +$27,142,591

VIA Pharmaceuticals, Inc.

Trading Symbol: CAQ
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 1,244,708 shares
Latest Transaction: Nov 07 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Werewolf Therapeutics, Inc.

Trading Symbol: HOWL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,752,787 shares
Latest Transaction: May 04 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 2,552,787
Shares Sold: 0
Share Difference: +2,552,787
Value Difference: -$12,800,000

XENOPORT INC

Trading Symbol: XNPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 2,746,650 shares
Latest Transaction: Feb 23 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

XERIS PHARMACEUTICALS INC

Trading Symbol: XERS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 857,821 shares
Latest Transaction: Feb 12 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 10x
Shares Bought: 2,498,666
Shares Sold: 143,530
Share Difference: +2,355,136
Value Difference: -$9,045,666

Latest Insider Trading Transactions of James E Flynn

Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 04 2021HOWLWerewolf Therapeut ...Flynn James E10% OwnerOption ExerciseC0.0015,195,09400
May 04 2021HOWLWerewolf Therapeut ...Flynn James E10% OwnerBuyP16.00800,00012,800,0002,552,7871.8 M to 2.6 M (+45.64 %)
May 04 2021HOWLWerewolf Therapeut ...Flynn James E10% OwnerBuyC0.001,752,78701,752,7870 to 1.8 M
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerOption ExerciseC0.00433,55100
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerOption ExerciseC0.001,301,62600
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerOption ExerciseC0.001,572,96000
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerBuyP16.00625,00010,000,0003,933,1373.3 M to 3.9 M (+18.89 %)

View all James E Flynn insider transactions.